Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence.
This study prospectively assessed the use, effectiveness, and sexual and psychosocial impact of self-injection treatment in 15 men with psychogenic impotence. Sixty percent dropped out of self-injection treatment by 6 months. Those who remained used self-injections about four times monthly with a 94% success rate. Frequency of intercourse and sexual satisfaction increased. Anxiety decreased, and trends toward improvement in depression and self-esteem were evident. Qualitative data indicated that performance anxiety was not alleviated, dependence upon injections for intercourse remained, symptom substitution did not occur, and capacity for intimacy was not improved.
Turner
L A
LA
Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH.
Althof
S E
SE
Levine
S B
SB
Risen
C B
CB
Bodner
D R
DR
Kursh
E D
ED
Resnick
M I
MI
D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000523:psychology; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D010410:Penile Erection / Q000187:drug effects; D012646:Self Administration
D010208:Papaverine